High Intensity Focused Ultrasound (HIFU) Therapy Market Research Report - Global Forecast till 2023

High Intensity Focused Ultrasound (HIFU) Therapy Market Research Report - Global Forecast till 2023

ID: MRFR/HC/0383-HCRR | July, 2018 | Region: Global | 110 pages | Half-Cooked Research Reports

High Intensity Focused Ultrasound (HIFU) Market Information: By Modality (Therapeutic Ultrasound, Hemostasis), By Method (Non-Invasive and Minimal-Invasive Method), By Application (Prostate Cancer, Uterine Fibroids, and others), By End Users (Diagnostic Centers, Hospitals, Research Centers) - Global Forecast till 2023


Market Scenario
High intensity focused ultrasound (HIFU) therapy kills cancer cells with high frequency sound waves. It can treat only a single tumor or a part of a large tumor and cannot be used to treat widespread tumors. Thus, the HIFU therapy is not suitable for the treatment of malignant tumor. This therapy is a novel, emergent and practices ultrasound waves that propagate through tissue media as energy carriers. HIFU therapy is a completely non-invasive technology that has great potential of tumor ablation, hemostasis, thrombolysis as well as targeted drug/gene delivery.  The therapy is also used to treat prostate cancer using high frequency ultrasound energy. It is broadly used in the field of interventional oncology due to its non-invasiveness, sharp treatment margins, and low complication rates. Additionally, the use of the technology in combination of other therapeutic and diagnostic modalities, such as targeted drug/gene-delivery, robotic surgery, and molecular imaging is expected to grow and have a revolutionary clinical impact over the forecast period. 


Rising prevalence of different types of cancers, especially, prostate cancer, kidney cancer, primary and secondary liver cancer, pancreatic cancer, and bladder cancer will boost growth of the market. According to the American Cancer Society, about 161,360 new cases of prostate cancer have been registered in the US in 2016.  Moreover, increasing development in medical technology and its wide-range applications used in the treatment of uterine fibroids, neurological disorders, cosmetic medicine, others have fueled growth of the market.


On the other hand, high cost of the treatment and certain adverse effects are likely to restrain the market’s growth over the assessment period.


The global high intensity focused ultrasound (HIFU) therapy market is expected to grow at a CAGR of 7.8% during the forecast period 2017-2023.


FIGURE 1 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Applications, 2016 (%)

High Intensity Focused Ultrasound Therapy Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Key Players in the Global High Intensity Focused Ultrasound (HIFU) Therapy Market 
Some of the key players in this market are Image Guided Therapy, EDAP TMS, SonaCare Medical, LLC, Theraclion, Chongqing Haifu Medical Technology Co., Ltd, Koninklijke Philips N.V., Shanghai A&S Co. LTD, Mianyang Sonic Electronic Ltd., Insightec, Alpinion Medical Systems, and FUS Instruments.


Intended Audience



  • High intensity focused ultrasound (HIFU) system/device supplies companies

  • High intensity focused ultrasound (HIFU) system/device providers

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Potential investors


Research Methodology

High Intensity Focused Ultrasound Therapy Market-
Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Segments                                                         
The global high intensity focused ultrasound (HIFU) therapy market is segmented on the basis of modality, which comprises of therapeutic ultrasound, hemostasis, lithotripsy, thrombolysis, immunomodulation, and others.


On the basis of the methods, the market is segmented into non-invasive method, and minimal invasive method.


On the basis of applications, the market is segmented into prostate cancer, uterine fibroids, neurological disorders, cosmetic medicine, and others.


On the basis of end users, the market is segmented into diagnostic centers, hospitals, research centers, and others.

Regional Analysis of the Global High Intensity Focused Ultrasound (HIFU) Therapy Market 
The Americas accounts for the largest share in the global high intensity focused ultrasound (HIFU) therapy market. It includes North America and South America.  North America dominates the market due to growing prevalence of cancers in this region, which  is one of the major driving factors for the growth of high intensity focused ultrasound (HIFU) therapy market.


Europe is the second highest revenue generating region in the global HIFU therapy market. Europe is mainly consist of Eastern Europe and Western Europe. More developed countries of Western Europe such as Germany, France, and the UK are holding the major market share, whereas the Eastern European countries are also growing at a significant rate. Owing to developing healthcare infrastructure and increasing healthcare expenditure, and growing adoption of HIFU therapy for the treatment of cancers and related diseases drive the growth of the HIFU therapy market.


In Asia Pacific, increasing government support for research & development in healthcare domain, growing number of cancer cases drives the growth of the market.


The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Modality

6.1 Introduction

6.2 Therapeutic Ultrasound

6.3 Hemostasis

6.4 Lithotripsy

6.5 Thrombolysis

6.6 Immunomodulation

6.7 Others

7 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Method

7.1 Introduction

7.2 Non-Invasive Method

7.3 Minimal Invasive Method

8 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Application

8.1 Introduction

8.2 Prostate Cancer

8.3 Uterine Fibroids

8.4 Neurological Disorders

8.5 Cosmetic Medicine

8.6 Others

9 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by End User

9.1 Introduction

9.2 Diagnostic Centers

9.3 Hospitals

9.4 Research Centers

9.5 Others

10 Global High Intensity Focused Ultrasound (HIFU) Therapy Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Image Guided Therapy

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 EDAP TMS

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 SonaCare Medical, LLC

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Theraclion

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Chongqing Haifu Medical Technology Co., Ltd

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Koninklijke Philips N.V.,

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Alpinion Medical Systems

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of High Intensity Focused Ultrasound (HIFU) Therapy Industry

14 Appendix